Wyeth Limited

NSE: WYETH

Wyeth News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Wyeth from all sources in a single place.

30 Mar 2016

Patent Office rejects divisional patent application of Wyeth

Business Standard

The patent authority refused to allow the divisional status of the application

30 Aug 2015

Patent Office refuses divisional application for Wyeth's antibiotic combination

Business Standard

The Patent Office has refused a divisional application of Wyeth's drug piperacillin and tazobactam injection

Is Wyeth Limited worth buying?

3 Votes:

Buy 33.33%

Hold 66.67%